Makers of generics should develop abuse-resistant oxycodone

04/22/2013 | New York Times (tiered subscription model), The

Makers of generic drugs should market their own abuse-resistant formulations of the painkiller OxyContin, or oxycodone, following an FDA ruling that will block the entry of generic versions of the original formulation from the market, according to this editorial.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI